King's College London

Research portal

Professor Andrew Tutt

Research interests

Andrew Tutt is Director of the Breast Cancer Now Research Unit at King’s College London and Honorary Consultant Clinical Oncologist, Breast Unit, GSTT.   Professor Tutt is also Professor of Breast Oncology and Head of Division of Breast Cancer Research and Director Breast Cancer Now Toby Robins Research Centre  at the Institute of Cancer Research.  He qualified in medicine from Bristol University in 1990. After postgraduate training in general medicine he trained in clinical oncology at the Royal Marsden Hospital before gaining a Research Training Fellowship from the Medical Research Council to work in Professor Alan Ashworth’s laboratory at The Institute of Cancer Research. Here he worked on functions of the BRCA2 breast cancer predisposition gene and was awarded his PhD in 2002. He cares for women with breast cancer as an oncologist in the multidisciplinary Breast Unit at Guy’s and St Thomas’ NHS Foundation Trust and is a member of St Gallen Early Breast Cancer International Consensus Panel developing international treatment guidelines. Professor Tutt is a faculty member of the section of Research Oncology at King’s College London School of Medicine and has been a Visiting Professor at British Columbia Cancer Agency and Jean Lubrano Visiting Scholar at Harvard Medical School.

 

Professor Tutt has, in collaboration with Professor Ashworth, developed a translational and clinical trial programme focusing on Triple Negative forms of Breast Cancer and cancers associated with functional deficiencies in BRCA1 and BRCA2. He has published papers from these programmes in the journals Nature, The New England Journal of Medicine, The Lancet and the Journal of Clinical Oncology. He is currently Chief Investigator for the UKCRN Triple Negative Trial actively recruiting in 65 Cancer Units around the UK, and is co-lead for a Triple Negative Breast Cancer Trial initiative for the Breast International Group. As Director of the Breakthrough Breast Cancer Research Unit at KCL Professor Tutt leads a laboratory programme aimed at the discovery and validation of biomarkers and potential therapy targets for Triple Negative Breast Cancer. He also advises Cancer Research UK and Cancer Research Technology on cancer therapy discovery as a member of the Discovery Committee.

Types of External academic engagement - Contribution to the work of national or international committees and working groups

NICE on Herceptin technology assessment

Andrew Tutt (Advisor)
2006 → …

Activity: OtherTypes of External academic engagement - Contribution to the work of national or international committees and working groups

Sit on CR-UK Discovery Committee

Andrew Tutt (Member)
2001 → …

Activity: OtherTypes of External academic engagement - Contribution to the work of national or international committees and working groups

Participation in conference

Novel Therapeutic Strategies for BRCA1 and BRCA2 associated cancers. Scandinavian Breast Cancer Group Annual Meeting Selfoss

Andrew Tutt (Keynote/plenary speaker)
2006 → …

Activity: Participating in or organising an eventParticipation in conference

Novel Therapeutic Strategies for BRCA1 and BRCA2 associated cancers. FORCE BRCA1 BRCA2 carrier convention Tampa

Andrew Tutt (Keynote/plenary speaker)
2006 → …

Activity: Participating in or organising an eventParticipation in conference

Novel Therapeutic Strategies for BRCA1 and BRCA2 associated cancers. KconFAB Familial Breast Cancer Conference Brisbane

Andrew Tutt (Keynote/plenary speaker)
2006 → …

Activity: Participating in or organising an eventParticipation in conference

Functional impairment of BRCA1 in Basal-like breast cancer. Basal Breast cancer Workshop Harvard Boston

Andrew Tutt (Keynote/plenary speaker)
2006 → …

Activity: Participating in or organising an eventParticipation in conference

Novel Therapeutic Strategies for BRCA1 and BRCA2 associated cancers. Anglo-Israeli BRCA1/2 Meeting Tel Aviv

Andrew Tutt (Keynote/plenary speaker)
2006 → …

Activity: Participating in or organising an eventParticipation in conference

Novel Therapeutic Strategies for BRCA1 and BRCA2 associated cancers. British Society of Human Genetics York

Andrew Tutt (Keynote/plenary speaker)
2006 → …

Activity: Participating in or organising an eventParticipation in conference

Targeting the Cancer Genome. ESMO Istanbul

Andrew Tutt (Keynote/plenary speaker)
2006 → …

Activity: Participating in or organising an eventParticipation in conference

Triple Negative Breast Cancer: How Shall we treat this new disease? NCRI meeting Birmingham

Andrew Tutt (Keynote/plenary speaker)
2006 → …

Activity: Participating in or organising an eventParticipation in conference

Novel Therapeutic Strategies for BRCA1 and BRCA2 associated cancers. NCRI Cancer Conference – Birmingham

Andrew Tutt (Keynote/plenary speaker)
Oct 2005 → …

Activity: Participating in or organising an eventParticipation in conference

Patient Selection: How far are we from individualized treatment. British Oncological Association Annual Scientific Meeting - Edinburgh

Andrew Tutt (Keynote/plenary speaker)
Sep 2004 → …

Activity: Participating in or organising an eventParticipation in conference

Publication peer-review

JCO (Journal)

Andrew Tutt (Editor)
2001 → …

Activity: Publication peer-review and editorial workPublication peer-review

European Journal of Cancer (Journal)

Andrew Tutt (Editor)
2001 → …

Activity: Publication peer-review and editorial workPublication peer-review

Oncogene (Journal)

Andrew Tutt (Editor)
2001 → …

Activity: Publication peer-review and editorial workPublication peer-review

Clinical Oncology (Journal)

Andrew Tutt (Editor)
2001 → …

Activity: Publication peer-review and editorial workPublication peer-review

The Lancet (Journal)

Andrew Tutt (Editor)
2001 → …

Activity: Publication peer-review and editorial workPublication peer-review

Types of Business and Community - Work on advisory panel to industry or government or non-government organisation

Types of External academic engagement - Membership of external research organisation

KCL Breast Tissue Bank Grant

Andrew Tutt (Member)
20062008

Activity: OtherTypes of External academic engagement - Membership of external research organisation

Validation Q-RT PCR prognostic signatures in FFPE breast cancer CELERA Dx

Andrew Tutt (Member)
20062007

Activity: OtherTypes of External academic engagement - Membership of external research organisation

CTAAC CRUK/Breakthrough Triple Negative Trial (TNT) CI

Andrew Tutt (Member)
20062012

Activity: OtherTypes of External academic engagement - Membership of external research organisation

KCL Experimental Cancer Medicine Centre Application (CRUK)

Andrew Tutt (Member)
20062008

Activity: OtherTypes of External academic engagement - Membership of external research organisation

CTAAC CRUK/Breakthrough Genetic Breast Cancer Trial (BRCA Trial) Co-CI

Andrew Tutt (Member)
20042008

Activity: OtherTypes of External academic engagement - Membership of external research organisation

Breakthrough Post Doctoral Clinician Scientist Fellowship

Andrew Tutt (Fellow)
20042009

Activity: OtherTypes of External academic engagement - Membership of external research organisation

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454